Chennai, Tamil Nadu (February 02, 2026) – Kidus Optimus, the early childhood learning wing of FIITJEE Global School, has been recognised as an Excellent Preschool at the Times Education Icons 2025-26, Chennai Schools, Pre Schools and Education Institutions Survey. This recognition brings attention to something often overlooked. The importance of the first seven years of a … [Read more...] about Kidus Optimus from FIITJEE Global School Recognised as Excellent Preschool at Times Education Icons 2025-26
Latest News
Incredible Design Showcases Two Iconic Republic Day Parade Tableaux Celebrating Ayush and the Legacy of Punyashloka Lokmata Devi Ahilyabai Holkar
New Delhi | Republic Day Parade 2026 - Incredible Design, a New Delhi–based multidisciplinary design studio, has conceptualised and delivered two landmark tableaux for the Republic Day Parade 2026, translating India’s civilisational wisdom, governance ethos, and cultural continuity into powerful national narratives. Designed for the Ministry of Ayush and the State of Madhya … [Read more...] about Incredible Design Showcases Two Iconic Republic Day Parade Tableaux Celebrating Ayush and the Legacy of Punyashloka Lokmata Devi Ahilyabai Holkar
New Data for Delhi: Reusable Mask Cuts Toxic Diesel Soot by 71% in Real-World Commute Study
Delhi/Mumbai/Bengaluru: As the capital's AQI again breaches the 'Severe' 400+ mark, a new study provides concrete data for millions seeking protection. Research from Queen Mary University of London, simulating Indian urban traffic, finds the reusable Totobobo mask reduces exposure to harmful black carbon (diesel soot) by an average of 71%—significantly outperforming other … [Read more...] about New Data for Delhi: Reusable Mask Cuts Toxic Diesel Soot by 71% in Real-World Commute Study
ImmunoACT announces partnership with Mango Sciences to bring the world’s first bridge financing plan and value-based offering for CAR-T therapy for cancer patients in India
Mumbai (Maharashtra) [India], December 2: ImmunoAdoptive Cell Therapy (ImmunoACT), the Mumbai, India-based pioneering research and cell and gene therapy development company, announced a strategic partnership with Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI company, to expand access and affordability of ImmunoACT's NexCAR19TM chimeric antigen … [Read more...] about ImmunoACT announces partnership with Mango Sciences to bring the world’s first bridge financing plan and value-based offering for CAR-T therapy for cancer patients in India
A New Hope in Prostate Cancer: How PSMA Treatment Is Changing the Game
By Charanjeet Singh, Associate Professor, Radiology, Anschutz Medical Center CO, USA. Prostate cancer is the second most common cancer in men worldwide. While many cases are treatable in early stages, advanced prostate cancer can be harder to manage. But there’s good news: a new kind of treatment, called PSMA therapy, is offering hope to men with difficult-to-treat prostate … [Read more...] about A New Hope in Prostate Cancer: How PSMA Treatment Is Changing the Game